What are control groups and placebos in clinical trials?
A control group provides a comparison for the approach being studied. In some trials it receives a placebo, such as a preparation without the active study drug; other trials use an active treatment or another comparison. Randomization and blinding describe how groups are assigned and who knows the assignment.
https://www.hopestage.com/research/learn/what-is-a-control-group-and-placebo
Key takeaways
- A control group does not always mean a placebo group.
- Random assignment does not necessarily give equal chances of every group.
- Ask what care and monitoring continue in each group before deciding.
On this page
Understand why researchers compare groups
Changes during a study can have several explanations. A comparison helps researchers interpret outcomes alongside what happens in another group. Ask what the particular comparison is designed to show and what its limits are. Not every study has the same design or uses a control group.
Find out what placebo means in this study
For a drug trial, a placebo does not contain the active study drug. Ask how it is used and whether participants also receive existing treatment. Do not infer that placebo means no care at all, or that usual medication necessarily continues. The consent discussion should make the actual arrangements clear.
Ask concrete questions before joining
Ask which group you could enter, what happens in each and what the team would do if your health changes. Request a plain-language explanation rather than relying on a technical acronym in the record.
| Topic | Question to ask |
|---|---|
| Control group | What is the comparison group receiving or doing? |
| Placebo | Could I receive it, and what care continues? |
| Randomization | What are my chances of each assignment? |
| Blinding | Who knows the assignment, and for how long? |
| Health concerns | How are concerns handled if the assignment is unknown? |
Check how randomization works
Randomization assigns participants by chance rather than letting them choose a group. It helps reduce selection bias. The allocation can differ between studies, so ask about your actual chances rather than assuming a fifty-fifty split. Decide whether you are comfortable with any of the possible assignments.
Ask who knows the group assignment
Blinding means specified people do not know the assigned group during part of the study. Labels such as double blind may need further explanation: ask which participants, clinicians or assessors are unaware. Ask about the procedure for an urgent clinical need to know, without trying to identify your group from symptoms.
Clarify when information becomes available
Ask whether and when you can learn your assignment and how that differs from receiving the overall results. Keep the team’s answer with your study documents. If not knowing the group would affect your decision, raise that before consenting.
Questions to keep for your next conversation
- Describe the comparison in your own words.
- Ask whether placebo is possible.
- Clarify what usual care continues in each group.
- Check the actual allocation chances.
- Ask who is blinded and how health concerns are handled.
- Ask whether and when assignments will be shared.
Questions and answers
Is every control group a placebo group?
No. The comparison can involve an active treatment, usual care or another arrangement. Check the specific study design.
Can I choose my group in a randomized trial?
Randomization uses chance to assign groups. Ask about the possible assignments before deciding whether to participate.
Does randomized mean a fifty-fifty chance?
Not necessarily. Studies can use different allocation ratios. Ask the team for the chances in this trial.
Will I know whether I receive placebo?
That depends on blinding and the disclosure plan. Ask who knows during the study and whether you can learn later.
Explore the current directory
Availability changes. Confirm local recruitment and eligibility with the research team. A directory listing does not establish payment or suitability.
Browse mental health clinical trials